Document is current

Article History

Received: 24 November 2025

Accepted: 3 July 2026

First Online: 8 July 2026

Declarations

:

: The authors declare no competing interests.

: This study received ethical approval from the Hospital Universitario La Princesa Drug Research Ethics Committee and obtained a favourable report from the Local Research Commission of the Primary Care Management of the Community of Madrid. All procedures were conducted in accordance with the ethical standards of the institutional and national research committees and with the principles outlined in the Declaration of Helsinki. Every method was performed in accordance with relevant guidelines and regulations. The requirement of informed consent from patients was waived, because this study is retrospective and does not contain individual personal information, since the data were obtained from a secondary database with anonymised and dissociated information as stablished by the current legislation at the time of the study. Also, ethical approval was granted by the Research Ethics Committee for Medicines (CEIm) of IDIAPJGol. Approval was obtained at the committee meeting held on 26 April 2023, with a subsequent amendment approved on 29 November 2023, under reference code 23/093-P.